- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 27 Jun 22 EFFECT Notice of effectiveness
- 24 Jun 22 424B3 Prospectus supplement
- 3 Jun 22 POS AM Prospectus update (post-effective amendment)
- 17 May 22 424B3 Prospectus supplement
- 17 May 22 424B3 Prospectus supplement
- 16 May 22 EFFECT Notice of effectiveness
- 9 May 22 AW Withdrawal of amendment
-
6 May 22 POS AM Prospectus update (post-effective amendment)
- 6 Apr 22 POS AM Prospectus update (post-effective amendment)
- 6 Apr 22 424B3 Prospectus supplement
- 10 Sep 21 424B4 Prospectus supplement with pricing info
- 10 Sep 21 EFFECT Notice of effectiveness
- 31 Aug 21 S-1 IPO registration
- 19 Apr 24 Prospectus update (post-effective amendment)
- 19 Apr 24 Prospectus update (post-effective amendment)
- 3 Jun 22 Prospectus update (post-effective amendment)
- 6 May 22 Prospectus update (post-effective amendment)
- 6 Apr 22 Prospectus update (post-effective amendment)
- 6 Apr 22 Prospectus update (post-effective amendment)
- 6 Apr 22 Prospectus update (post-effective amendment)
Exhibit 23.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Post-Effective Amendment No.1 to Registration Statement of 180 Life Sciences Corp. on Form S-1 (File No. 333-259209) of our report dated March 30, 2022, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of 180 Life Sciences Corp. as of December 31, 2021 and 2020 and for each of the two years in the period ended December 31, 2021, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.
/s/ Marcum llp
Marcum llp
San Francisco, CA
May 6, 2022